Ligand Pharmaceuticals Inc. Announces Third Quarter Results

November 9, 2011 |

1 min read

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (the “Company” or “Ligand”) today announced financial results for the three and nine months ended September 30, 2011 and provided a business update.

Earnings

MORE ON THIS TOPIC

Two men walking on separate winding paths that merge into a single large upward arrow representing business partnership and shared goals, 3d render

Mergers & acquisitions

Telix buys ITM for $1.65B in ‘supercritical’ radiopharma M&A

September 21, 2026

·

3 min read

·

Tristan Manalac

Contemporary art collage. Businessman standing under heavy pressure. Working conditions. Concept of struggle, failure, success, competition, motivation, concentration, crisis, fear Copy space for ad

Obesity

Novo buys three early-stage obesity assets from Kallyope as investor pressure mounts

September 21, 2026

·

1 min read

·

Tristan Manalac

Symbolic image: Tablets, US Dollar and China - Dependence on the Chinese pharmaceutical industry

China

China plans to transform biotech sector into $522B powerhouse by 2030

September 18, 2026

·

2 min read

·

Annalee Armstrong

The intertwining wires flash in different colors, 3D rendering illustration.

IPO

Electra lights up with $350M IPO for pivotal immune-disease drug development

September 18, 2026

·

1 min read

·

Gabrielle Masson